Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, announced today that it has partnered with Ascend Therapeutics ("Ascend") to co-promote SPRIX® (ketorolac tromethamine) Nasal Spray to more than 9,000 women's healthcare practitioners (HCPs).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.